The forecast indicates a steady increase in higher education expenditure on R&D in medical and health sciences in Japan, with values rising from $6.9 billion in 2024 to $7.14 billion in 2028. In 2023, this expenditure stood at $6.84 billion, reflecting a consistent upward trend.
Year-on-year growth rates are moderate, averaging approximately 0.87% annually. The compound annual growth rate (CAGR) over this forecast period (2024-2028) is a modest yet positive indicator, sustaining support for advancements in medical research and development.
Future trends to watch include increased investment in digital health technologies, potential changes in government funding policies, and the emergence of new research fields that may impact spending priorities.
